Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-K/A for the period ended Sep 30, 2021

Filed with the SEC on May 31, 2022 and accepted by EDGAR at May 31, 2022, 20:31 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2020-10-01 to 2021-09-30$178.1kus-gaap:Revenues
Cost of revenue12 months2020-10-01 to 2021-09-30$275.9kus-gaap:CostOfRevenue
Gross profit12 months2020-10-01 to 2021-09-30−$97.7kus-gaap:GrossProfit
Research and development12 months2020-10-01 to 2021-09-30$3.9mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2020-10-01 to 2021-09-30−$10.2mus-gaap:OperatingIncomeLoss
Net income12 months2020-10-01 to 2021-09-30−$9.9mus-gaap:NetIncomeLoss
Operating cash flow12 months2020-10-01 to 2021-09-30−$8.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2020-10-01 to 2021-09-30$67.1kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-09-30$6.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-09-30$7.3mus-gaap:AssetsCurrent
Total assetsAt period end2021-09-30$7.9mus-gaap:Assets
Current liabilitiesAt period end2021-09-30$1.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-09-30$1.4mus-gaap:Liabilities
Shareholders' equityAt period end2021-09-30$6.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-22-030420. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.